Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sharps Technology Inc. - Common Stock (NQ: STSS )

3.450 -0.020 (-0.58%)
Streaming Delayed Price Updated: 10:39 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sharps Technology Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
RedChip Launches 'Small Stocks, Big Money' Podcast
Via ACCESSWIRE
Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
Why Sharps Technology Stock Is Trading Lower
Sharps Technology Inc (NASDAQ: STSS) shares are trading lower after the company announced a $3.8 million private placement at $1.69 per share. What Else? 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
Gainers Unique Fabricating, Inc. (NYSE: UFAB) gained 88.8% to $0.34 in pre-market trading after gaining around 4% on Tuesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! 
Via InvestorPlace
Sharps Technology Issues Update Letter To Shareholders From CEO Robert Hayes
Sharps Technology, Inc. (NASDAQ: STSS) (NASDAQ: STSSW) issued a shareholder update from Robert Hayes, the Company's Chief Executive Officer. Dear Fellow Shareholders: 
Via Benzinga
BullFrog AI and Sharps Technology Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
By David Willey, Benzinga 
Via TheNewswire.com
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? 
Via News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. 
Via Benzinga
BARK And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
By David Willey, Benzinga 
Via TheNewswire.com
Topics Initial Public Offering
Exposures COVID-19 Securities Market
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO 
Via News Direct
Topics Initial Public Offering
Exposures COVID-19 Securities Market
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in... 
Via Benzinga
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.8 Million Private Placement for Sharps Technology, Inc. (NASDAQ:STSS)
Via ACCESSWIRE
Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the stock with a Buy rating and a $3.30 price target. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
By David Willey, Benzinga 
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products 
Via News Direct
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the... 
Via Benzinga
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029 
Via News Direct
Exposures COVID-19
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
By David Willey, Benzinga 
Via TheNewswire.com
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry 
Via News Direct
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
The drug delivery system is a device that enables the introduction of a drug in the body and improves its efficacy and safety by controlling the rate, time, and place of release of drugs in the body.... 
Via TheNewswire.com
Exposures COVID-19
Sharps Technology To Launch Next-Gen Prefillable Syringe Systems In Collaboration With Nephron Pharmaceuticals In 2023
Sharps Technology, Inc. 
Via Benzinga
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.